BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 19780621)

  • 21. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
    Chen H; Parkinson JA; Morris RE; Sadler PJ
    J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
    Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
    Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ
    Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium(II) and ruthenium(IV) complexes containing kappa1-P-, kappa2-P,O-, and kappa3-P,N,O-iminophosphorane-phosphine ligands Ph2PCH2P[=NP(=O)(OR)2]Ph2 (R = Et, Ph): synthesis, reactivity, theoretical studies, and catalytic activity in transfer hydrogenation of cyclohexanone.
    Cadierno V; Crochet P; Díez J; García-Alvarez J; García-Garrido SE; Gimeno J; García-Granda S; Rodríguez MA
    Inorg Chem; 2003 May; 42(10):3293-307. PubMed ID: 12739971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel half-sandwich Ru(II)-hydroxamate complexes: synthesis, characterization and equilibrium study in aqueous solution.
    Buglyó P; Farkas E
    Dalton Trans; 2009 Oct; (38):8063-70. PubMed ID: 19771370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
    Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
    Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes.
    Liu HK; Wang F; Parkinson JA; Bella J; Sadler PJ
    Chemistry; 2006 Aug; 12(23):6151-65. PubMed ID: 16807967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
    Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex formation between Ru(η(6)-p-cym)(H2O)3]2+ and (O,O) donor ligands with biological relevance in aqueous solution.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2010 Nov; 39(42):10272-8. PubMed ID: 20922244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
    Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
    J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
    Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
    Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
    Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
    Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
    Barry NP; Edafe F; Therrien B
    Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.
    Grguric-Sipka S; Stepanenko IN; Lazic JM; Bartel C; Jakupec MA; Arion VB; Keppler BK
    Dalton Trans; 2009 May; (17):3334-9. PubMed ID: 19421637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cancer cell growth by ruthenium complexes.
    Iida J; Bell-Loncella ET; Purazo ML; Lu Y; Dorchak J; Clancy R; Slavik J; Cutler ML; Shriver CD
    J Transl Med; 2016 Feb; 14():48. PubMed ID: 26867596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.